|
|
Article: London-Based Double Helix Consulting Launches US Division for Strategic Pricing, Reimbursement and Market Access Solutions.
- Article from:
- PR Newswire
- Article date:
- January 26, 2009
CopyrightCOPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
LONDON, Jan. 26 /PRNewswire/ -- Double Helix Consulting US (DHC US), headed by Andrew M. Baker, President, joins a multidisciplinary team of highly experienced strategic pricing, reimbursement and market access consultants with extensive experience across the healthcare industry as well as strong commercial, governmental and academic links, who provide customer-centric market access strategies to clients in the pharmaceutical, biotechnology and medical device industries. DHC US provides services spanning the product lifecycle, including the following:
-- Product value message development and testing
-- Commercial assessment
-- Lifecycle planning
-- ...
Related newspaper, magazine, and journal articles:
|
|
Article: Destabilization of the DNA double helix in cancer ...
Townsend Letter for Doctors and Patients;
June 1, 2004 ;
700+ words
... ... that wrap around each other forming a double helix. (2) The concept that DNA contains ... disruption in the structure of the DNA double helix is a central factor in carcinogenesis ... for changes in the stability of the double helix. Beljanski used two assays to show ...
|
|